Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 41 - 60 of 108
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • »
Disparities in evaluation, management, and mortality persist in patient populations where bladder cancer is less common.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
The overall cancer rate among adolescents and young adults is on a gradual increase, thus creating the need for oncology programs geared towards young adults and adolescents.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
Stephen Quake, PhD, spoke to CANCER BUZZ about the application of liquid biopsies across multiple cancer stages and their potential to improve patient outcomes, minimize financial toxicity, and create health equity through greater testing access and lower cost.
As in other areas of the country, COVID-19 surges during the past two years have led to the cancellation, postponement, or downsizing of planned community outreach and screening events at Munson Healthcare in Michigan. Oncologists at Munson think it’s likely that northern Michigan will see an increase in late-stage cancer cases as a result.
Cancer screenings may have decreased since the pandemic, but the need for them hasn't. “You can continue to do the work you’re doing; we just need to be mindful," says Nora Katurakes, RN, MSN, OCN. "We can’t just stop living. … We’re going to have to learn how to live with COVID-19 in our community.”
In 2020, medical experts warned that COVID-19 could, over time, have a substantial impact on cancer outcomes due to delayed or missed cancer screenings for patients. To obtain a better perspective of how cancer programs’ screening and outreach education efforts are recovering from pandemic pressures, ACCCBuzz spoke to four cancer programs across the country.
To obtain an on-the-ground perspective of how cancer programs’ screening and outreach education efforts are reacting to pandemic pressures, ACCCBuzz spoke to four cancer programs across the country that will be featured in four separate blog posts in January 2022. For the first blog in the series, we spoke to Renea Duffin, MPA, vice president of cancer support and outreach at Mary Bird Perkins Cancer …
Genetic counselors can help individuals understand their risk of cancer, make medical decisions based on relevant genetic findings, take steps to lower their cancer risk, and make informed decisions about the most effective course of treatment after a cancer diagnosis. But despite the importance of the services they provide, genetic counselors are not considered to be providers, and their services …
Because transportation disruptions can result in missed appointments, treatment delays, and potentially adverse health outcomes, we must help ensure that our patients have access to safe and reliable means of transportation.
Learn the 10 feasible and impactful “how-tos” Summit participants identified within three domains—care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
An integrated precision tracking program ensures proper follow-up care and surveillance for survivors of colorectal cancer.
To help cancer programs and practices establish and maintain robust financial navigation programs, ACCC's Financial Advocacy Network recently developed the “Ready, Set, Go! Financial Advocacy Playbook” for all members of the cancer care team—particularly those who provide any level of financial advocacy services.
The U.S. Food and Drug Administration's Oncology Center of Excellence, Project Community, has designated June 17 to June 23 as National Black Family Cancer Awareness Week. The week coincides with Juneteenth—an important date in our nation’s history that marks and celebrates the end of slavery in the United States. By participating in the #BlackFamCan social media effort, ACCC is building support and …
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
The disparities in prostate cancer are striking. In the United States, Black men continue to experience a far greater incidence of new prostate cancers and are 2.2 to 2.5 times more likely to die from the disease than any other racial/ethnic group. Taking action to close these gaps is an imperative for moving toward equitable cancer care.
Led by the Prevent Cancer Foundation, ACCC has joined more than 300 organizations in signing a letter urging the passage of the MCED Screening Coverage Act, which will help cancer care providers be able to use the latest testing technologies to improve quality of life and better patient outcomes.
On March 9, the U.S. Preventive Services Task Force (USPSTF) updated its recommendation for annual lung cancer screening. USPSTF estimates that these changes will almost double the number of at-risk individuals who are eligible for lung cancer screening.
    Displaying results 41 - 60 of 108
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • »